Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Hum Psychopharmacol ; 39(3): e2890, 2024 May.
Article in English | MEDLINE | ID: mdl-38180732

ABSTRACT

OBJECTIVE: In psychiatry, polypharmacy or high psychotropic drug doses increase adverse drug event (ADE) prevalence. However, the full relationship between polypharmacy and ADEs is unclear, and few studies have evaluated dose equivalents for psychotropic drugs for ADEs. Thus, we conducted a retrospective analysis to clarify the effects of polypharmacy and chlorpromazine (CP)-, diazepam (DAP)-, and imipramine- equivalent doses on all ADEs in inpatients. METHODS: Psychiatric inpatients in a Japanese hospital from April 1, 2016 to March 31, 2018, were enrolled. ADE severity and causality were assessed. Multiple logistic regression analyses were performed to evaluate ADE risk factors. RESULTS: Among 462 patients analyzed, out of 471 patients enrolled, 145 (31.4%) experienced ADEs. The causality assessment determined that "possible" was 96.5%. The most common ADEs were nervous system disorders (35%). Multiple logistic regression analyses indicated an increase in ADE prevalence with the number of drugs used (≥5; p = 0.026); CP-equivalent dose (p = 0.048); and endocrine, nutritional, and metabolic disorders (p = 0.045). DAP-equivalent dose; infectious and parasitic diseases; and injury, poisoning, and consequences of other external causes decreased ADE prevalence (p = 0.047, 0.022, and 0.021, respectively). CONCLUSIONS: Avoiding polypharmacy in psychiatric inpatients and adjusting drug regimens to safe equivalent doses could reduce ADEs during hospitalization.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Hospitals, General , Inpatients , Mental Disorders , Polypharmacy , Psychotropic Drugs , Humans , Male , Female , Japan/epidemiology , Middle Aged , Psychotropic Drugs/adverse effects , Psychotropic Drugs/administration & dosage , Retrospective Studies , Mental Disorders/drug therapy , Mental Disorders/epidemiology , Aged , Adult , Prevalence , Drug-Related Side Effects and Adverse Reactions/epidemiology , Risk Factors , Dose-Response Relationship, Drug
2.
J Radiat Res ; 49(1): 49-54, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18094531

ABSTRACT

It has not been verified whether allopurinol application is beneficial in decreasing the severity of radiation-induced oral mucositis and dermatitis. Rats were divided into 4 groups and received 15 Gy irradiation on the left whisker pad. Group 1 received only irradiation. Group 2 was maintained by applying allopurinol/carrageenan-mixed gel (allopurinol gel) continuously from 2 days before to 20 days after irradiation. Group 3 had allopurinol gel applied for 20 days after radiation. Group 4 was maintained by applying carrageenan gel continuously from 2 days before to 20 days after irradiation. The intra oral mucosal and acute skin reactions were assessed daily using mucositis and skin score systems. The escape thresholds for mechanical stimulation to the left whisker pad were measured daily. In addition, the irradiated tissues at the endpoint of this study were compared with naïve tissue. Escape threshold in group 2 was significantly higher than that in group 1, and mucositis and skin scores were much improved compared with those of group 1. Concerning escape threshold, mucositis and skin scores in group 3 began to improve 10 days after irradiation. Group 4 showed severe symptoms of mucositis and dermatitis to the same extent as that observed in group 1. In the histophathological study, the tissues of group 1 showed severe inflammatory reactions, compared with those of group 2. These results suggest that allopurinol gel application can mitigate inflammation reactions associated with radiation-induced oral mucositis and dermatitis.


Subject(s)
Allopurinol/therapeutic use , Mouth Mucosa/radiation effects , Radiation Injuries, Experimental/drug therapy , Radiodermatitis/drug therapy , Skin/radiation effects , Stomatitis/drug therapy , Animals , Gels , Male , Mouth Mucosa/pathology , Rats , Rats, Sprague-Dawley , Skin/pathology , Stomatitis/etiology , X-Rays/adverse effects
3.
Seishin Shinkeigaku Zasshi ; 104(8): 656-89, 2002.
Article in Japanese | MEDLINE | ID: mdl-12451718

ABSTRACT

The author investigated middle- to long-term therapeutic response among 14 patients with anorexia nervosa treated for one year or longer. The factors associated with recovery were: (1) Onset in pre-adolescence; (2) Short duration of disorder prior to consultation; (3) Core symptoms restricted to eating; (4) Presence of three clinical characteristics (improvement of relationships with family, improvement in physical comorbidity, experience of "hitting bottom"). The factors associated with deterioration were: (1) Long duration of disorder prior to consultation; (2) Core symptoms of binge-eating with purging; (3) Presence of clinical features of borderline personality disorder; (4) Presence of two clinical characteristics (worsening relationships with family, therapist involved in manipulation by patient). In terms of the psychopathology of anorexia nervosa, anorectic patients are constantly pursuing a "thin body image" due to distrust in human relationships. One of the most important steps towards recovering from anorexia nervosa is therefore to re-establish a basic trust in human relationships.


Subject(s)
Anorexia Nervosa/psychology , Psychopathology , Adolescent , Adult , Age Factors , Anorexia Nervosa/therapy , Body Image , Child , Female , Humans , Sex Factors , Time Factors , Treatment Outcome , Trust
4.
Gan To Kagaku Ryoho ; 29(3): 465-7, 2002 Mar.
Article in Japanese | MEDLINE | ID: mdl-11915741

ABSTRACT

We performed preoperative combined therapy using nedaplatin (CDGP) and radiation in 12 patients with squamous cell carcinoma originating from the oral cavity and maxillary sinus, and examined for any adverse events that may have occurred during this therapeutic regimen. Regarding the irradiation, external irradiation utilizing a 6 MV linac (linear accelerator) at a dose of 2.0 Gy/day was performed 5 times a week, with the target total radiation dose set at 40 Gy. In addition, CDGP was intravenously administered 30 minutes before irradiation at a dose of 5 mg/m2/day. Mucositis was observed in all 12 subjects, however, the severity was observed to be grade 1-2 with no major differences in comparison to the patients given standard radiation monotherapy. Two subjects developed grade 3 leucopenia and were thus given granulocyte colony stimulating factor (G-CSF). In addition, grade 2 and grade 3 thrombocytopenia were both observed in one subject each. The subject with grade 3 thrombocytopenia required a platelet transfusion during surgery. No marked changes in serum creatinine levels were noted. These findings are therefore considered to provide evidence supporting the safety of this combination therapy.


Subject(s)
Antineoplastic Agents/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/radiotherapy , Mouth Neoplasms/drug therapy , Mouth Neoplasms/radiotherapy , Preoperative Care , Adult , Aged , Drug Administration Schedule , Female , Humans , Male , Middle Aged , Organoplatinum Compounds/administration & dosage , Radiotherapy, High-Energy
SELECTION OF CITATIONS
SEARCH DETAIL
...